C5a causes limited, polymorphonuclear cell-independent, mesenteric ischemia/reperfusion-induced injury

Clinical Immunology

Volumn 108, Issue 3, 2003, Pages 263-273

  Fleming, Sherry D ^a,b   Mastellos, Dimitrios ^c   Karpel Massler, Georg ^a   Shea Donohue, Terez ^b,d   Lambris, John D ^c   Tsokos, George C ^a,b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Adhesion molecules; Complement; Inflammation; Mucosa; Neutrophils; Rodent

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ISCHEMIA; LUNG INJURY; MALE; MESENTERY; MOUSE; MUCOSA INFLAMMATION; NEUTROPHIL; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; TISSUE INJURY;

EID: 0141565363     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(03)00160-8     Document Type: Article

References (44)

1. Kilgore K.S., Todd R.F., Lucchesi B.R. Reperfusion injury. Gallin J.I., Snyderman R. Inflammation Basic Principles and Clinical Correlates . 1999;1047-1060 Lippincott Williams and Wilkins, Philadelphia.
2. Kyriakides C., Austen W.G., Wang Y., Favussa J., Moore F.D., Hechtman H.B. Neutrophil mediated remote organ injury after lower torso ischemia and reperfusion is selectin and complement dependent. J. Trauma. 48:2000;32.
3. Williams J.P., Pechet T.T.V., Weiser M.R., Reid R., Kobzik L., Moore F.D., Carroll M.C., Hechtman H.B. Intestinal reperfusion injury is mediated by IgM and complement. J. Appl. Physiol. 86:1999;938-942.
4. Conner W.C., Gallagher C.M., Miner T.J., Tavaf-Motamen K.M., Wolcott H., Shea-Donohue T. Neutrophil priming state predicts capillary leak after gut ischemia in rats. J. Surg. Res. 84:1999;24-30.
5. Biffl W.L., Moore E.E. Role of the gut in multiple organ failure. Grenvik A., Ayres S.M., Holbrook P.R., Shoemaker W.C. Textbook of Critical Care. 4th ed. 2000;1627-1635 W.B. Saunders Co, Philadelphia.
6. Rinder C.S., Rinder H.M., Smith B.R., Fitch J.C.K., Smith M.J., Tracey J.B., Matis L.A., Squinto S.P., Rollins S.A. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation duringextracorporeal circulation. J. Clin. Invest. 96:1995;1564-1572.
7. Vakeva A.P., Agah A., Rollins S.A., Matis L.A., Li L., Stahl G.L. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion role of the terminal complement components and inhibition by anti-C5 therapy . Circulation. 97:1998;2259-2267.
8. Vakeva A., Meri S. Complement activation and regulator expression after anoxic injury of human endothelial cells. APMIS. 106:1998;1149-1156.
9. Wada K., Montalto M.C., Stahl G.L. Inhibition of complement C5 reduces local and remote organ injury after intestinal ishcmenia/reperfusion in the rat. Gastroenterology. 120:2001;126-133.
10. Wang Y., Rollins S.A., Madri J.A., Matis L.A. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc. Natl. Acad. Sci. 92:1995;8955-8959.
11. Fleming S.D., Anderson J., Wilson F., Shea-Donohue T., Tsokos G.C. C5 is required for CD49d expression on neutrophils and VCAM expression on vascular endothelial cells following mesenteric ischemia/reperfusion. Clin. Immunol. 106:2002;55-64.
12. Kohl J. Anaphylatoxins and infectious and non-infectious inflammatory diseases. Mol. Immunol. 38:2001;175-187.
13. Wetsel R.A., Kildsgaard J., Haviland D.L. Complement anaphylatoxins (C3a, C4a, C5a) and their receptors (C3aR, C5aR/CD88) as therapeutic targets in inflammation. Lambris J.D., Holers V.M. Therapeutic Interventions in the Complement System. 2000;113-153 Humana Press, Totowa, NJ.
14. Binder R., Kress A., Kan G., Hermann K., Kirschfink M. Neurtophil priming by cytokines and vitamin D binding protein (Ge-globulin) impact on C5a-mediated chemotaxis, degranulation and respiratory burst . Mol. Immunol. 36:1999;885-892.
15. Tyagi S., Klickstein L.B., Nicholson-Weller A. C5a-stimulated human neutrophils use a subset of β2 integrins to support the adhesion-dependent phase of superoxide production. J. Leukoc. Biol. 68:2000;679-686.
16. Perianayagam M.C., Balakrishnan V.S., King A.J., Pereira B.J.G., Jaber B.L. C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. Kidney Int. 61:2002;456-463.
17. Tofukuji M., Stahl G.L., Metais C., Tomita M., Agah A., Bianchi c., Fink M.P., Sellke F.W. Mesenteric dysfunction after cardiopulmonary bypass role of complement C5a . Ann Thorac. Surg. 69:2000;799-807.
18. Bless N.M., Warner R.L., Padgaonkar V.A., Lentsch A.B., Czermak B.J., Schmal H., Friedl H.P., Ward P.A. Roles for C-X-C chemokines and C5a in lung injury after hindlimb ischemia-reperfusion. Am. J. Physiol. 276:1999;L57-L63.
19. Huber-Lang M.S., Sarma J.V., McGuire S.R., Lu K.T., Guo R.F., Padgaonkar V.A., Younkin E.M., Laudes I.J., Riedemann N.C., Younger J.G., Ward P.A. Protective effects of anti-C5a peptide antibodies in experimental sepsis. FASEB J. 15:2001;568-570.
20. Huber-Lang M., Sarma J.V., Lu K.T., McGuire S.R., Padgaonkar V.A., Guo R.F., Younkin E.M., Kunkel R.G., Ding J., Erickson R., Curnutte J.T., Ward P.A. Role of C5a in multiorgan failure during sepsis. J. Immunol. 166:2001;1193-1199.
21. Czermak B.J., Sarma V., Pierson C.L., Warner R.L., Huber-Lang M., Bless N.M., Schmal H., Friedl H.P., Ward P.A. Protective effects of C5a blockade in sepsis. Nat. Med. 5:1999;788-792.
22. Riedemann N.C., Guo R.F., Neff T.A., Laudes I.J., Keller K.A., Sarma J.V., Markiewski M.M., Mastellos D., Strey C.W., Pierson C.L., Lambris J.D., Zetoune F.S., Ward P.A. Increased C5a receptor expression in sepsis. J. Clin. Invest. 110:2002;101-108.
23. Mulligan M.S., Schmid E., Beck-Schimmer B., Till G.O., Friedl H.P., Brauer R., Hugli T.E., Miyasaka M., Warner R.L., Johnson K.J., Ward P.A. Requirement and role of C5a in acute lung inflammatory injury in rats. J. Clin. Invest. 98:1996;503-512.
24. Rothermel E., Gotze O., Zahn S., Schlaf G. Analysis of the tissue distribution of the rat C5a receptor and inhibition of C5a-mediated effects through the use of two MoAbs. Scand. J. Immunol. 52:2000;401-410.
25. Pellas T.C., Boyar W., Oostrum J.V., Wasvary J., Fryer L.R., Pastor G., Sills M., Braunwalder A., Yarwood D.R., Kramer R., Kimble E., Hadala J., Haston W., Moreira-Ludewig R., Uziel-Fusi S., Peters P., Bill K., Wennogle L. Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo. J. Immunol. 160:1998;5616-5621.
26. Heller T., Hennecke M., Baumann U., Gessner J.E., Meyer zu Vilsendorf A., Baensch M., Boulay F., Kola A., Klos A., Bautsch W., Kohl J. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury. J. Immunol. 163:1999;985-994.
27. Haynes D.R., Harkin D.G., Bignold L.P., Hutchens M.J., Taylor S.M., Fairlie D.P. Inhibition of C5a-induced neutrophil chemotaxis and macrophage cytokine production in vitro by a new C5a receptor antagonist. Biochem. Pharmacol. 60:2000;729-733.
28. Arumugam T.V., Shiels I.A., Woodruff T.M., Reid R.C., Fairlie D.P., Taylor S.M. Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine. J. Surg. Res. 103:2002;260-267.
29. Finch A.M., Wong A.K., Paczkowski N.J., Wadi S.K., Craik D.J., Fairlie D.P., Taylor S.M. Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. J. Med. Chem. 42:1999;1962-1974.
30. Mastellos D., Papadimitriou J.C., Franchini S., Tsonis P.A., Lambris J.D. A novel role of complement mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration . J. Immunol. 166:2001;2479-2486.
31. Rehrig S., Fleming S.D., Anderson J., Gutheridge J.M., Rakstang J., McQueen C., Holers V.M., Tsokos G.C., Shea-Donohue T. Complement inhibitor, Crry-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice. J. Immunol. 167:2001;5921-5927.
32. Fleming S.D., Shea-Donohue T., Gutheridge J.M., Kulik L., Waldschmidt T.J., Gipson M.G., Tsokos G.C., Holers V.M. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J. Immunol. 169:2002;2126-2133.
33. Chiu C.-J., McArdle A.H., Brown R., Scott H.J., Gurd F.N. Intestinal mucosal lesion in low-flow states. Arch. Surg. 101:1970;478-483.
34. Czermak B.J., Lentsch A.B., Bless N.M., Schmal H., Friedl H.P., Ward P.A. Synergistic enhancement of chemokine generation and lung injury by C5a or the membrane attack complex of complement. Am. J. Physiol. 154:1999;1513-1524.
35. 74. J. Biol. Chem. 277:2002;7165-7169.
36. Woodruff T.M., Strachan A.J., Sanderson S.D., Monk P.N., Wong A.K., Fairlie D.P., Taylor S.M. Species dependence for binding of small molecule agonist and antagonists tot he C5a receptor on polymorphonuclear leukocytes. Inflammation. 25:2001;171-177.
37. Niculescu F., Rus H. Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells. Immunol. Res. 24:2001;191-199.
38. 4-integrin an alternative pathway for neutrophil recruitment? Immunol. Today. 20:1999;545-550.
39. Ivey C.L., Williams F.M., Collins P.D., Jose P.J., Williams T.J. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit evidence for a role for C5a and interleukin-8 . J. Clin. Invest. 95:1995;2720-2728.
40. Bowden R.A., Ding Z.-M., Donnachie E.M., Petersen T.K., Michael L.H., Ballantyne C.M., Burns A.R. Role of α4 integrin and VCAM-1 in CD18-independent neutrophil migration across mouse cardiac endothelium. Circ. Res. 90:2002;562-569.
41. 4 integrin-dependent leukocyte recruitment does not require VCAM-1 in a chronic model of inflammation. J. Immunol. 164:2000;3337-3344.
42. Raeburn C.D., Calkins C.M., Zimmerman M.A., Song Y., Ao L., Banerjee A., Meng X., Harken A.H. Vascular cell adhesion molecule-1 expression is obligatory for endotoxin-induced myocardial neutrophil accumulation and contractile dysfunction. Surgery. 130:2001;319-325.
43. Sun Z., Wang X., Lasson A., Bojesson A., Annborn M., Anderson R. Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion, Scand. J. Gastroenterol. 1:2001;55-65.
44. Ng C.K.D., Deshpande S.S., Irani K., Alevriadou B.R. Adhesion of flowing monocytes to hypoxia-reoxygenation-exposed endothelial cells role of Rac1, ROS, and VCAM-1 . Am. J. Physiol. 283:2002;C93-C102.